Nuclear factor κB activity is increased in peripheral blood mononuclear cells of children affected by atopic and non-atopic eczema

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 1, 2007, Pages 59-67

  Angelini, Federica ^a,d   Di Matteo, G ^a   Balestrero, S ^a   Brunetti, E ^b   Mancino, G ^b   Rossi, P ^a,c   Galli, E ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Allergy; Atopic dermatitis; NF B

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; CYTOKINE; DNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DNA BINDING; ECZEMA; ENZYME INHIBITION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; BIOSYNTHESIS; BLOOD; CELL NUCLEUS; CHEMISTRY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MONOCYTE; PATHOLOGY; PRESCHOOL CHILD; SKIN TEST;

ANTI-INFLAMMATORY AGENTS; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DERMATITIS, ATOPIC; DNA; ECZEMA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MONOCYTES; NF-KAPPA B; SKIN TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947718343     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000107     Document Type: Article

References (46)

1. Johansson S.G., T. Bieber, R. Dahl, et al. 2004. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization October 2003. J. Allergy Clin. Immunol. 113:832.
2. Akdis C.A. and M. Akdis. 2003. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin. Exp. Allergy 33:1618.
3. Galli E., R. Ciccone, P. Rossi, A. Casati, E. Brunetti and G. Mancino. 2003. AD: molecular mechanism clinical aspects and new therapeutical approaches. Curr. Mol. Med. 3:127.
4. Williams H.C. 2005. Clinical practice. Atopic dermatitis. N. Engl. J. Med. 352:2314.
5. Boguniewicz M., Y.M. Donald and D.Y. Leung. 2006. Atopic Dermatitis. J. Allergy Clin. Immunol. 113:651.
6. Ghosh S., M.J. May and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16:225.
7. Li Q. and I.M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725.
8. Chen C.C., C.L. Rosenbloom, D.C. Anderson and A.M. Manning. 1995. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IkappaB-alpha phosphorylation. J. Immunol. 155:3538.
9. Santamaria Babi L.F., M.T. Perez Soler, C. Hauser and K. Blaser. 1995. Skin-homing T cells in human cutaneous allergic inflammation. Immunol. Res. 14:317.
10. Grewe M., C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka and J. Krutmann. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19:359.
11. Shimada Y., K. Takehara and S. Sato. 2004. Both Th2 and Th1 chemokines are in sera from patients with atopic dermatitis. J. Dermatol. Sci. 34:201.
12. Girolomoni G., S. Sebastiani, C. Albanesi and A. Cavani. 2001. T-cell subpopulations in the development of atopic and contact allergy. Curr. Opin. Immunol. 13:733.
13. Campbell I.K., S. Gerondakis, K. O'Donnell and I.P. Wicks. 2000. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J. Clin. Invest. 105:1799.
14. Schreiber S., S. Nikolaus and J. Hampe. 1998. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477.
15. Collins T. and M.I. Cybulsky. 2001. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest. 107:255.
16. Bureau F., G. Bonizzi, N. Kirschvink, S. Delhalle. D. Desmecht, M.P. Merville, V. Bours and P. Lekeux. 2000. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am. J. Respir. Crit. Care. Med. 161:1314.
17. Gagliardo R., P. Chanez, M. Mathieu, A. Bruno, G. Costanzo, C. Gougat, I. Vachier, J. Bousquet, G. Bonsignore and A.M. Vignola. 2003. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am. J. Respir. Crit. Care. Med. 168:1190.
18. Butt C., S. Sun, L. Peddle, C. Greenwood, S. Hamilton, D. Gladman and P. Rahman. 2005. Association of nuclear factor-κB in psoriatic arthritis. J. Rheumatol. 32:9.
19. Johansen C., E. Flindt, K. Kragballe, J. Henningsen, M. Westergaard, K. Kristiansen and L. Iversen. 2005. Inverse regulation of the nuclear factor-κB binding to the p53 and interleukin-8 kB response elements in lesional psoriatic skin. J. Invest. Dermatol. 124:1284.
20. Lizzul P.F., A. Aphale, R. Malavivya, Y. Sun, S. Masud, V. Dombrovskiy and A.B. Gottlieb. 2005. Differential expression of phosphorylated NF-κB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept. J. Invest. Dermatol. 124:1275.
21. Dieckhoff K., P. Graf, B. Beinhauer, C. Schwaerzler, J.M. Carballido, C. Neumann, K. Zachmann and T. Jung. 2005. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients. Exp. Dermatol. 14:17.
22. Yang L., L. Cohn, D.H. Zhang, R. Homer, A. Ray and P. Ray. 1998. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739.
23. Donovan C.E., D.A. Mark, H.Z. He, H.C. Liou, L. Kobzik, Y. Wang, G.T. De Sanctis, D.L. Perkins and P.W. Finn. 1999. NF-kappa B/Rel transcription factors:c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163:6827.
24. Poynter M.E., C.G. Irvin and Y.M. Janssen-Heininger. 2002. Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am. J. Pathol. 160:1325.
25. Barton D., H. Hogen Esch and F. Weih. 2000. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 30:2323.
26. Klement J.F., N.R. Rice, B.D. Car, S.J. Abbondanzo, G.D. Powers, P.H. Bhatt, C.H. Chen, C.A. Rosen and C.L. Stewart. 1996. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341.
27. Tenda Y., M. Yamashita, M.Y. Kimura, A. Hasegawa, C. Shimizu, M. Kitajima, A. Onodera, A. Suzuki, N. Seki and T. Nakayama. 2006. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice. J. Allergy Clin. Immunol. 118:725.
28. Galli E., L. Chini, V. Moschese, F. Paone, A. Menichelli, G. Fraioli and P. Rossi. 1994. Methylprednisolone bolus: a novel therapy for severe atopic dermatitis. Acta Paediatr. 83:315.
29. European Task Force on Atopic Dermatitis. 1993. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 18:23.
30. Andrews N.C. and D.V. Fallen 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
31. Hart L.A., V.L. Krishnan, I.M. Adcock, P.J. Barnes and K.F. Chung. 1998. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am. J. Respir. Crit. Care Med. 158:1585.
32. Marienfeld R., M.J. May, I. Berberich, E. Serfling, S. Ghosh and M. Neumann. 2003. Rel-B forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278:19852.
33. Takao J., T. Yudate, A. Das, S. Shikano, M. Bonkobara, K. Ariizumi and P.D. Cruz. 2003. Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth. Br. J. Dermatol. 148:680.
34. Hu Y., V. Baud, T. Oga, K.I. Kim, K. Yoshida and M. Karin. 2001. IKK-alpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710.
35. Zonana J., M.E. Elder, L.C. Schneider, S.J. Orlow, C. Moss, M. Golabi, S.K. Shapira, P.A. Farndon, D.W. Wara, S.A. Emmal and B.M. Ferguson. 2000. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J. Hum. Genet. 67:1555.
36. Courtois G., A. Smahi, J. Reichenbach, et al. 2003. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest. 112:1108.
37. Bell S., K. Degitz, M. Quirling, N. Jilg, S. Page and K. Brand. 2003. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal 15:1.
38. Breuer K., A. Kapp and T. Werfel. 2001. Bacterial infections and atopic dermatitis. Allergy 56:1034.
39. Faergemann J. 2002. Atopic dermatitis and fungi. Clin. Microbiol. Rev. 15:545.
40. Mambula S.S., K. Sau, P. Henneke, D.T. Golenbock and S.M Levitz. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277:39320.
41. Meier A., C.J. Kirschning, T. Nikolaus, H. Wagner, J. Heesemann and F. Ebel. 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell. Microbiol. 5:561.
42. Wollenberg A., Wetzel S., Burgdorf W.H. and J. Haas. 2003. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J. Allergy Clin. Immunol. 112:667.
43. Auphan N., J.A. Di Donato, C. Rosette, A. Helmberg and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286.
44. De Bosscher K., W. Vanden Berghe, L. Vermeulen, S. Plaisance, E. Boone and G. Haegeman. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. USA 97:3919.
45. Henderson W.R. Jr., E.Y. Chi, J.L. Teo, C. Nguyen and M. Kahn. 2002. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J. Immunol. 169:5294.
46. Nakamura H., M. Aoki, K. Tamai, M. Oishi, T. Ogihara, Y. Kaneda and R. Morishita. 2002. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther. 9:1221.